Solid oral dosage form development covers a wide range of dosage forms, including simple methods of powder belending to form capsules, granulation and tabletting and more complex approaches used to enhance delivery of poorly soluble or unstable API. Help is available to navigate the route through the best approach to achieve the desired goal.
New chemical entity development
The important thing here is to get into man as fast as possible, usual the smallest amount of API, but having done the appropriate amount of work to ensure exposure of the compound in the trial.
Advice can be provided on strategy, outsource management and data interpretation. This covers the entire process from discovery to the production of clinical material. Including preformulation, form selection, stability, formulation approaches, manufacture of CT materials.
Generic development or life cycle management
Advice can be provided on how best to approach different stages in the product life cycle.